Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura

NCT01713855 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10

Enrollment

INDIV

Sponsor class

Conditions

Idiopathic Thrombocytopenic Purpura
Immune Thrombocytopenic Purpura

Interventions

BIOLOGICAL: Inactivated Trivalent Influenza vaccine

Sponsor

Neufeld, Ellis J, MD, PhD

Collaborators

[object Object]